Explore more publications!

Second Group of Palestinians Crosses into Gaza via Rafah

(MENAFN) A second group of Palestinians arrived at the Rafah crossing on Tuesday to complete entry procedures and return to Gaza, according to reports from Egyptian media.

The returnees had previously been receiving medical treatment in hospitals across Egypt and reached the crossing earlier in the day to finalize the necessary administrative steps before entering Gaza.

The arrivals follow the partial reopening of the Rafah terminal on Monday. Around 50 Palestinians are expected to return to Gaza, while approximately 150 patients and their companions are scheduled to leave the enclave for medical care in Egypt.

Gaza health authorities estimate that nearly 22,000 patients are awaiting the full reopening of the crossing, which serves as a crucial humanitarian route. Israel captured the Rafah crossing in May 2024, nearly nine months into its ongoing war on Gaza that has resulted in over 71,000 deaths and more than 171,000 injuries since October 2023.

The terminal was originally scheduled to reopen in October under the first phase of a ceasefire agreement, but Israel delayed it until the release of its last captive in Gaza, which occurred last week.

Despite the ceasefire, attacks have continued, with more than 500 people killed and over 1,300 injured since October 10, according to Gaza’s media office.

MENAFN03022026000045017640ID1110687009


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions